The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 Upregulation in Osteosarcoma Preclinical Models

Title
The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 Upregulation in Osteosarcoma Preclinical Models
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 19, Issue 8, Pages 2117-2131
Publisher
American Association for Cancer Research (AACR)
Online
2013-02-23
DOI
10.1158/1078-0432.ccr-12-2293

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now